SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/266104"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/266104" > Potential risk of b...

Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes.

Tygesen, H (författare)
Andersson, Bert, 1952 (författare)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Hjärt-kärlinstitutionen,Wallenberg Laboratory,Cardiovascular Institute
Di Lenarda, A (författare)
visa fler...
Rundqvist, Bengt, 1950 (författare)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
Sinagra, G (författare)
Hjalmarson, Åke, 1937 (författare)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Wallenberglaboratoriet,Cardiovascular Institute,Wallenberg Laboratory
Waagstein, Finn, 1938 (författare)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Hjärt-kärlinstitutionen,Wallenberg Laboratory,Cardiovascular Institute
Wennerblom, Bertil, 1940 (författare)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
visa färre...
 (creator_code:org_t)
1999
1999
Engelska.
Ingår i: International journal of cardiology. - 0167-5273. ; 68:2, s. 171-7
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Beta-Blockers reduce mortality in patients with congestive heart failure and a proposed mechanism has been changes of autonomic tone. Heart rate variability is a non-invasive tool to estimate cardiac autonomic tone. The aim was to study changes of heart rate variability in patients with congestive heart failure on placebo, on the beta1-selective antagonist metoprolol or 24 h after metoprolol withdrawal. Forty-five patients with congestive heart failure were studied with Holter recordings. Heart rate variability measurements were performed before, after 6-12 months of treatment with 150 mg metoprolol/placebo, or 24 h after discontinued metoprolol. After treatment, patients on beta-blockade had a significantly longer mean RR interval and changes of heart rate variability, suggesting elevated vagal tone. Patients monitored in the rebound phase of beta-blocker withdrawal had a significant vagal reduction to the level of the placebo group. There was also a nonsignificant trend towards increased sympathetic tone (LF/HF over 24 h), compared with the beta-blockade group. Heart rate variability indicates an elevated vagal tone during treatment with metoprolol but beta-blockade withdrawal shifts the autonomic balance towards lower vagal and higher sympathetic tone within 24 h. These results could imply a potential risk when abruptly discontinuing beta-blockade medication in these patients.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Adolescent
Adrenergic beta-Antagonists
adverse effects
Adult
Aged
Electrocardiography
Ambulatory
drug effects
Female
Follow-Up Studies
Heart Failure
drug therapy
physiopathology
Heart Rate
drug effects
Humans
Male
Metoprolol
adverse effects
Middle Aged
Myocardial Ischemia
chemically induced
physiopathology
Prognosis
Retrospective Studies
Risk Factors
Substance Withdrawal Syndrome
physiopathology
Vagus Nerve
drug effects
physiopathology
Ventricular Fibrillation
chemically induced
physiopathology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy